AIM2 and ischemia: Overall, our study signifies a critical turning point in understanding the regulation of AIM2-pyroptosis and mitophagy under ischemia–reperfusion conditions, supporting the exploration of Sirt6-enriched adipose stem cell-derived exosomes as a practical clinical treatment.